Zha, Shan
- Columbia University · Pediatrics (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #8,557
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2011 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Pediatrics
NIH Funding · FY2023
Linked Award Amount
$1.1M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#8,557
By linked amount among FY2023 PIs
Earliest Year Loaded
2011
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Zha, Shan as a PI. Multi-PI records show the full award amount for context.
- 5R01CA271595-02R01Contact PIThe non-catalytic function of PARP2 in DNA repair and cancer therapyColumbia University · Pediatrics (NIH department code)$579.8Kaward amount
- 5R01CA275184-02R01Contact PIThe role of DNA-PKcs in DNA repair, lymphocyte development, RNA metabolism and tumor suppressionColumbia University · Pediatrics (NIH department code)$565.7Kaward amount
Award organization
Organizations that administered FY2023 awards listing Zha, Shan as a PI.
FY2023 award administered by Columbia University (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2011First NIH AwardColumbia University
- 2012$500K Cumulative Funding
- 2014$1M Cumulative Funding
- 2015R01 Grant Holder
- 2016$2M Cumulative Funding
- 2017Entered Top 50% NationallyRanked #6090
- 2018Entered Top 25% NationallyRanked #4447
- 2019$5M Cumulative Funding
- 2022$10M Cumulative Funding